Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
US Army
Colorcon
Fuji
Daiichi Sankyo

Generated: April 21, 2019

DrugPatentWatch Database Preview

FIRDAPSE Drug Profile

« Back to Dashboard

Which patents cover Firdapse, and when can generic versions of Firdapse launch?

Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA.

The generic ingredient in FIRDAPSE is amifampridine phosphate. One supplier is listed for this compound. Additional details are available on the amifampridine phosphate profile page.

Summary for FIRDAPSE
Drug patent expirations by year for FIRDAPSE
Generic Entry Opportunity Date for FIRDAPSE
Generic Entry Date for FIRDAPSE*:
Constraining patent/regulatory exclusivity:
INDICATED FOR THE TREATMENT OF LAMBERT-EATON MYASTHENIC SYNDROME (LEMS) IN ADULTS
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for FIRDAPSE
006D401
3-amino-4-pyridinylamine
3,4 Diaminopyridine
3,4-DAP
3,4-diamine-pyridine
3,4-diamino pyridine
3,4-diamino-pyridine
3,4-Diamino[3,4-b]pyridine
3,4-DIAMINOPYRIDINE
3,4-Diaminopyridine, 98%
3,4-Diaminopyridine, 98% 1g
3,4-Diammoniopyridinium
3,4-Pyridinediamine
4-DAP
4,5-Diaminopyridine
4CH-015905
5-22-11-00266 (Beilstein Handbook Reference)
54-96-6
54-96-6 3,4-diaminopyridine
76674-EP2305250A1
76674-EP2308868A1
AB0014693
AB1000895
AC-907/34116043
AC1L1LEX
ACMC-209lkh
ACN-026994
ACN-S003268
ACT01546
AK-26114
AKOS000672436
ALBB-005969
AM20070030
amifampridin
Amifampridin (3,4-Diaminopyridine)
Amifampridine
Amifampridine (INN)
Amifampridine [USAN:INN:BAN]
AMPD00217
AN-41664
ANW-32223
BBL013269
BC222447
BCP22343
BDBM50416493
BP-12781
BR-26114
BRN 0110232
CAS-54-96-6
CD-463
CHEBI:135948
CHEMBL354077
CL0116
CM14022
CS-2778
CTK1H0917
D10228
D219
DB-011105
Diamino-3,4 pyridine
Diamino-3,4-Pyridine
DSSTox_CID_26715
DSSTox_GSID_46715
DSSTox_RID_81847
DTXSID6046715
EINECS 200-220-9
F0001-1409
FT-0614203
GTPL8032
HC150250
HMS2233K06
HY-14946
InChI=1/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8
J-610017
KB-28130
KS-000002IW
KSC270S1P
L421
L89
LS-131135
LS00018
M-3620
MCULE-5478459845
MFCD00006401
MLS001304911
MLS001333181
MLS001333182
MolPort-000-139-949
NCGC00167560-01
NCGC00167560-02
NSC 521760
NSC-521760
NSC521760
OYTKINVCDFNREN-UHFFFAOYSA-N
PS-9273
PubChem1295
pyridine-3,4-diamine
Pyridine, 3,4-diamino-
Pyridine,4-diamino-
QC-1804
RP00483
RTC-062692
RU4S6E2G0J
SBB004341
SC-05267
SC10
SCHEMBL21273
SMR000752913
ST2413732
ST50946583
STK503647
TC-062692
TL8003599
Tox21_112555
Tox21_112555_1
TRA0066361
UNII-RU4S6E2G0J
W-105592
WLN: T6NJ CZ DZ
WT559
Zenas
ZINC164000

US Patents and Regulatory Information for FIRDAPSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Catalyst Pharms FIRDAPSE amifampridine phosphate TABLET;ORAL 208078-001 Nov 28, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Catalyst Pharms FIRDAPSE amifampridine phosphate TABLET;ORAL 208078-001 Nov 28, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Covington
Mallinckrodt
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.